NM23-H1 expression of head and neck squamous cell carcinoma in association with the response to cisplatin treatment.

Oncotarget · 2014 · PMC4202131 · PMID 25277180

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

marginal significancep=0.056so close (0.05 < p ≤ 0.1)

Chi-square test with Yates( correction showed that more patients with NM23-H1-negative tumors (14/25) had tumor recurrence than those with NM23-H1-positive tumors (5/21), with marginal significance (p=0.056).

also in 5,069 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.